Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Rad Laboratories Inc Reaffirms FY 2013 Revenue Guidance-Conference Call


Tuesday, 7 May 2013 05:00pm EDT 

Bio-Rad Laboratories Inc announced that for fiscal 2013, the Company is cautiously optimistic of achieving a currency-neutral sales growth guidance of 3% to 3.5% for the base business that the Company provided in February. The Company reported revenue of $2.069 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.15 billion for fiscal 2013. 

Company Quote

121.31
0.53 +0.44%
19 Dec 2014